longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Q32 Bio

QTTB

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Editas Medicine -16.41%, consensus target above spot

    Weekly Review·Sep 12 at 08:10 AM
    EDIT+1.65%
  • Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buy

    Weekly Review·Sep 12 at 07:49 AM
    CAI-3.75%
  • The Nasdaq Biotechnology Index closed down more than 1.7%. Dyne's stock price fell 16.85%, Silence Therapeutics dropped 8.90%, Q32 Bio decreased 8.38%, and Summit Therapeutics Plc. fell 8.13%. Terns Pharmaceuticals rose 6.48%, Wave Life Sciences increased 14.58%, Applied Therapeutics gained 15.32%, and Cartesian Therapeutics climbed 18.08%

    Wallstreetcn·Dec 9, 2025 at 10:15 PM
    SLN-2.05%WVE-2.48%
  • The Nasdaq Biotechnology Index closed up 1.85%, outperforming both small-cap indices and the three major U.S. stock indices

    Wallstreetcn·Jul 16, 2025 at 08:42 PM
    PRME-1.27%SMMT-1.81%